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Moyamoya as a cause of occlusive recurrent cerebral angiopathy has beendescribed mostly inJapan
although cases have been reported worldwide. In our review of local literature, no case has so far been
described in this part of the world. A case of a young boy with recurrent seizures and ischemic attacks
is being presented who was diagnosed as having nioyamoya disease.
Case Report
A three and half years old male child presented with a one day histozy of high grade fever, rash, right
sided focal seizures and right hemiparesis. He was well and had developed normally till 9 months of
age when he contracted measles and had a generalized tonic clonic seizure. One year later he had
another generalized seizure with fever and a month later a third seizure which was focal in nature after
which he developed hemiparesis. The weakness was more pronounced in the leg which gradually
improved. CT scan revealed mild focal atrophic changes. EEG showed mild focal slowing with sharp
waves in the right mid and posterior temporal region. He was placed on carbamazepine 10mg/kg/day
and sodium valproate 30 mg/kg/day, no seizures occurred till this adniisston.
On examination the patient was drowsy with a Glasgow Coma scale of 8/15 and was having right sided
focal seizures. On neurological examination, right sided focal signs were seen with power grade 2/5,
tone increased, reflexes grade 3+ and plantars upgoing. Rest of the examination was normal.
CSF examination showed a cell count of 2/mm3, proteins of 43 mg/dland sugar 69 mg/dl. Culture was
negative. Hemoglobin, hernatocrit, electrolytes, calcium, alanine transferase were normal. CT scan
head showed multiple circumscribed areas of low density in both cerebral hemispheres. On postcontrast scan, there was some irregularity of arteries in the middle cerebral cistern and anterior
interhemisphoric fissure. Subsequent to the CT findings, a hemoglobin electrophoresis, immune
profile, ECG and echocardiogram were done which were all normal. Immune profile showed ANA to
be +++ve (peripheral) anti DNA was 0.6 lU/mi (0.6-6.0), anticardiolipin 1gm, Anticardiolipin lgG and
cystine screen were normal.
He was managed with I/V fluids, carbamazepine and sodium vaiproate. Neurological improvement
followed with a better sensorium and decreased weakness of right side. MRI showed evidence of
multiple flow void areas in the deep grey niatter suggestive of dilated collateral channels (Figure I).

There was also evidence of high signal areas in both cerebral hemispheres on T2 weighted images
consistent with ischemic infarct. Four vessel cerebral angiogram showed occlusion in the supraclinoid
portion of internal carotid arteiy bilaterally with multiple telangiectatic collaterals seen in the basal
ganglia region on both sides (Figure 2).

These gave a typical "puff" of smoke” appearance (Figure 3).

Filling of the pericallosal arteries through collateral vessels from prominent middle meningeal vessels
was also observed. Filling of the vertebral and the basilar artery and its branches was seen on contrast
studies. All these findings conforned with progressive idiopathic arteriopathy of childhood
(Moyainoya).
Although clinically, the patient has shown considerable improvement, lie still has moderate motor
aphasia with mild weakness in right arm and leg and a hemparetic gait. He is being managed
conservatively with physiotherapy and speech training. Vascular surgery is being considered as an
option for prevention of further ischemic events.
Discussion
Moyamoya disease is a chronic and progressive occlusive cerebral vascular disorder, first described by
Suzuki and Takaku1.
The term Moyamoya in Japanese denotes “something hazy, like a puff of smoke” and refers to the
angiographic appearance of the wispy network of collateral vessels at the base of the brain that
represents this vascular anomaly2,3.
Moyamoya disease occurs much more frequently in Japan but has been reported sporadically from all
over the world. There seem to be two definite peaks of age incidence, one in children less than 10 years

and the other in the 3rd decade. The majority of cases are hospitalized within 2 years of onset.
The exact etiology of Moyamoya disease is obscure. Majority of cases have no predisposing factors4.
The moyainoya syndrome is associated with certain HLA phenotypes, Fanconi’s anemia, Down
Syndrome, Von recklinghausen’s disease5-8, peripheral vascular occlusive disease, trauma, therapeutic
irradiation of the head (especially for sellar and suprasellar lesions) and a variety of infections
including tonsillitis, leptospirosis and tuberculosis9-10. The finding ofautoantibodies in patients
\\vithMoyamoya supports and immunological pathogenesis11.
In children, the presentation is more in the form of transient. ischemic attacks (TIA), seizures or rarely
strokes, with permanent deficits in recurrent TIAs or seizures.
Seizures focal or generalised occur commonly in children. They are easily controlled by anticonvulsant
therapy.
Headaches are frequent in the older pediatric patients and mental deterioration is seen in cases with
recurrent ischemic attacks. Considerable improvement in the IQ scores after arevascularization
procedure has been observed12. The clinical course may appear to stabilize despite angiographic
evidence of progression. But the formation of anastomotic channels is in-sufficient to provide alternate
flGW and preVent clinical deterioration. The rate of clinical decline varies considerably in each patient.
Various diagnostic tools are available for evaluation, as EEGs, CT scan and MRI13 but cerebral
angiography confirms the diagnosis.
The angiographic findings are characteristic, classically revealing symmetrical stenosis or occlusion of
both carotid forks, associated with abnormal vascular network called Moyamoya (puff of smoke) in the
basal ganglia.
Although no specific treatment has been reported14, steroids are considered effective in certain cases,
especially those with involuntary movements and (ii) in the actual phase of recurrent ischemic attack.
The mechanism of action is not clear1. A number of surgical angioplastic procedures have been
attempred13 But all arc in the pioneering stages. If the revascularization procedures could prevent or
minimize the progression of cerebral ischemia remain a controversial issue.
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